| A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment X Xu, MA Khan, DJ Burgess International Journal of Pharmaceutics 419 (1-2), 52-59, 2011 | 181 | 2011 |
| Freeze-Anneal-Thaw Cycling of Unilamellar Liposomes: Effect on Encapsulation Efficiency AP Costa, X Xu, DJ Burgess Pharmaceutical Research, 2013 | 164 | 2013 |
| Predicting hydrophilic drug encapsulation inside unilamellar liposomes X Xu, MA Khan, DJ Burgess International Journal of Pharmaceutics 423 (2), 410-418, 2012 | 147 | 2012 |
| A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale X Xu, MA Khan, DJ Burgess International Journal of Pharmaceutics 423 (2), 543-553, 2012 | 144 | 2012 |
| Protein encapsulation in unilamellar liposomes: High encapsulation efficiency and a novel technique to assess lipid-protein interaction X Xu, A Costa, DJ Burgess Pharmaceutical Research 29, 1919-1931, 2012 | 127 | 2012 |
| A two-stage reverse dialysis in vitro dissolution testing method for targeted liposomes X Xu, MA Khan, DJ Burgess International Journal of Pharmaceutics 426 (1-2), 211-218, 2012 | 120 | 2012 |
| Development of performance matrix for generic product equivalence of acyclovir topical creams YSR Krishnaiah, X Xu, Z Rahman, Y Yang, U Katragadda, R Lionberger, ... International journal of pharmaceutics 475 (1-2), 110-122, 2014 | 88 | 2014 |
| Application of quality by design to formulation and processing of protein liposomes X Xu, AP Costa, MA Khan, DJ Burgess International Journal of Pharmaceutics 434 (1-2), 349-359, 2012 | 78 | 2012 |
| Probing the mechanism of bupivacaine drug release from multivesicular liposomes S Manna, Y Wu, Y Wang, B Koo, L Chen, P Petrochenko, Y Dong, S Choi, ... Journal of Controlled Release 294, 279-287, 2019 | 76 | 2019 |
| Formulation and Process Factors Influencing Product Quality and In Vitro Performance of Ophthalmic Ointments X Xu, M Al-Ghabeish, Z Rahman, YSR Krishnaiah, F Yerlikaya, Y Yang, ... International Journal of Pharmaceutics, 2015 | 75 | 2015 |
| Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach S Kumar, X Xu, R Gokhale, DJ Burgess International Journal of Pharmaceutics 464 (1-2), 34-45, 2014 | 63 | 2014 |
| Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing A Gupta, AP Costa, X Xu, SL Lee, CN Cruz, Q Bao, DJ Burgess International journal of pharmaceutics 583, 119340, 2020 | 58 | 2020 |
| Quality by Design approach for studying the impact of formulation and process variables on product quality of oral disintegrating films S Mazumder, N Pavurala, P Manda, X Xu, C Cruz, YSR Krishnaiah International Journal of Pharmaceutics 527 (1-2), 151-160, 2017 | 57 | 2017 |
| Assessing impact of formulation and process variables on in-vitro performance of directly compressed abuse deterrent formulations Z Rahman, Y Yang, M Korang-Yeboah, A Siddiqui, X Xu, M Ashraf, ... International journal of pharmaceutics 502 (1-2), 138-150, 2016 | 49 | 2016 |
| Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion Z Rahman, X Xu, U Katragadda, YSR Krishnaiah, L Yu, MA Khan Molecular pharmaceutics 11 (3), 787-799, 2014 | 49 | 2014 |
| Kinetics of Drug Release from Ointments: Role of Transient-Boundary Layer X Xu, M Al-Ghabeish, YSR Krishnaiah, Z Rahman, MA Khan International Journal of Pharmaceutics, 2015 | 43 | 2015 |
| Liposome Formation Using a Coaxial Turbulent Jet in Co-Flow AP Costa, X Xu, MA Khan, DJ Burgess Pharmaceutical Research, 2015 | 42 | 2015 |
| Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment M Al-Ghabeish, X Xu, YSR Krishnaiah, Z Rahman, Y Yang, MA Khan. International Journal of Pharmaceutics, 2015 | 38 | 2015 |
| Machine learning models for predicting cytotoxicity of nanomaterials Z Ji, W Guo, EL Wood, J Liu, S Sakkiah, X Xu, TA Patterson, H Hong Chemical Research in Toxicology 35 (2), 125-139, 2022 | 36 | 2022 |
| How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities K Tyner, N Zheng, S Choi, X Xu, P Zou, W Jiang, C Guo, C Cruz AAPS Journal, 2017 | 33 | 2017 |
Diane J. BurgessUniversity of Connecticut Board of Trustees Distinguished Professor of PharmaceuticsVerified email at uconn.edu